IS

Indira Suyog Pednekar

Active Director Designated Partner DIN 11745898
DIN 11745898 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Indira Suyog Pednekar

Data last updated:

Indira Suyog Pednekar is a Designated Partner at Rari Healthtech Innovations Llp (since 2026).

DIN 11745898
Primary Designation Designated Partner
First Appointment 27 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 May 20262026Active

Board colleagues of Indira Suyog Pednekar

NameDINCompanyDesignation
Leena Virendra Thakur11745899Rari Healthtech Innovations LlpDesignated Partner
Yugandhara Sandip Khairnar11745900Rari Healthtech Innovations LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rari Healthtech Innovations Llp
Premium access

Shareholding and investment profile for Indira Suyog Pednekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indira Suyog Pednekar

Indira Suyog Pednekar currently holds 1 directorship: Rari Healthtech Innovations Llp (Designated Partner, since 27 May 2026).

Indira Suyog Pednekar was first appointed on 27 May 2026 as Designated Partner at Rari Healthtech Innovations Llp.

The current boards of Indira Suyog Pednekar's companies include Leena Virendra Thakur (Rari Healthtech Innovations Llp), Yugandhara Sandip Khairnar (Rari Healthtech Innovations Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available